Patents Assigned to ULTRAGENYX PHARMACEUTICAL INC.
  • Patent number: 9457068
    Abstract: The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: October 4, 2016
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Steven Jungles, Gabrielle Morris, Jeff Grubb, Michael Vellard, Emil D. Kakkis
  • Patent number: 9457067
    Abstract: The present application relates to sialylated glycoprotein compositions and methods of their use in treating various conditions and disorders.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: October 4, 2016
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Steven Jungles, Gabrielle Morris, Jeff Grubb, Michael Vellard, Emil D. Kakkis
  • Patent number: 9241896
    Abstract: Extended release formulations, methods of making, and methods of use, for example, in treatment of sialic acid deficiencies.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: January 26, 2016
    Assignee: ULTRAGENYX PHARMACEUTICAL INC.
    Inventor: Emil Kakkis
  • Patent number: 9221858
    Abstract: The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.
    Type: Grant
    Filed: August 15, 2014
    Date of Patent: December 29, 2015
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Emil Kakkis, Steven Jungles, He Zhao
  • Publication number: 20150038693
    Abstract: The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.
    Type: Application
    Filed: August 15, 2014
    Publication date: February 5, 2015
    Applicant: ULTRAGENYX PHARMACEUTICAL INC.
    Inventors: Emil KAKKIS, Steven JUNGLES, He ZHAO
  • Patent number: 8840926
    Abstract: The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.
    Type: Grant
    Filed: October 24, 2012
    Date of Patent: September 23, 2014
    Assignee: Ultragenyx Pharmaceutical Inc.
    Inventors: Emil Kaskkis, Steven Jungles, He Zhao
  • Publication number: 20140113876
    Abstract: The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).
    Type: Application
    Filed: September 20, 2013
    Publication date: April 24, 2014
    Applicant: ULTRAGENYX PHARMACEUTICAL INC.
    Inventors: Yiumo CHAN, Steve JUNGLES, Emil KAKKIS
  • Publication number: 20140094505
    Abstract: The present invention relates to methods of monitoring and assessing sialic acid deficiency treatment as well as to methods of predicting/determining responsiveness to treatment for a sialic acid deficiency using biomarkers. Sialic acid deficiencies include for example Hereditary Inclusion Body Myopathy (HIBM).
    Type: Application
    Filed: September 20, 2013
    Publication date: April 3, 2014
    Applicant: Ultragenyx Pharmaceutical Inc.
    Inventors: Yiumo CHAN, Steve Jungles, Emil Kakkis
  • Publication number: 20130273160
    Abstract: The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.
    Type: Application
    Filed: July 13, 2011
    Publication date: October 17, 2013
    Applicant: Ultragenyx Pharmaceutical Inc.
    Inventor: Emil Kakkis
  • Publication number: 20130225513
    Abstract: The present invention relates to compositions and methods for treating sialic acid deficiencies comprising extended release formulations.
    Type: Application
    Filed: January 18, 2013
    Publication date: August 29, 2013
    Applicant: Ultragenyx Pharmaceutical Inc.
    Inventor: Ultragenyx Pharmaceutical Inc.
  • Publication number: 20130122094
    Abstract: The present invention provides sialic acid analogs and their compositions useful for the treatment of sialic acid deficiencies.
    Type: Application
    Filed: October 24, 2012
    Publication date: May 16, 2013
    Applicant: ULTRAGENYX PHARMACEUTICAL, INC.
    Inventor: ULTRAGENYX PHARMACEUTICAL, INC.
  • Publication number: 20130109637
    Abstract: Extended release formulations, methods of making, and methods of use, for example, in treatment of sialic acid deficiencies.
    Type: Application
    Filed: October 24, 2012
    Publication date: May 2, 2013
    Applicants: ULTRAGENYX PHARMACEUTICAL INC., AAIPHARMA SERVICES CORP
    Inventors: AAIPHARMA SERVICES CORP, ULTRAGENYX PHARMACEUTICAL INC.